Cargando…
Treatment of intrabony periodontal defects using rhFGF‐2 in combination with deproteinized bovine bone mineral or rhFGF‐2 alone: A 6‐month randomized controlled trial
AIM: To evaluate the use of recombinant human fibroblast growth factor (rhFGF)‐2 in combination with deproteinized bovine bone mineral (DBBM) compared with rhFGF‐2 alone, in the treatment of intrabony periodontal defects. MATERIALS AND METHODS: Patients with periodontitis who had received initial pe...
Autores principales: | Saito, Atsushi, Bizenjima, Takahiro, Takeuchi, Takahiro, Suzuki, Eiichi, Sato, Masahiro, Yoshikawa, Kouki, Kitamura, Yurie, Matsugami, Daisuke, Aoki, Hideto, Kita, Daichi, Imamura, Kentaro, Irokawa, Daisuke, Seshima, Fumi, Tomita, Sachiyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899590/ https://www.ncbi.nlm.nih.gov/pubmed/30758076 http://dx.doi.org/10.1111/jcpe.13086 |
Ejemplares similares
-
Periodontal surgery using rhFGF‐2 with deproteinized bovine bone mineral or rhFGF‐2 alone: 2‐year follow‐up of a randomized controlled trial
por: Aoki, Hideto, et al.
Publicado: (2020) -
Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial
por: Seshima, Fumi, et al.
Publicado: (2022) -
Efficient treatment of Parkinson’s disease using ultrasonography-guided rhFGF20 proteoliposomes
por: Niu, Jianlou, et al.
Publicado: (2018) -
Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo
por: Reker, Ditte, et al.
Publicado: (2017) -
Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice
por: Zhao, Longwei, et al.
Publicado: (2017)